LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.01
 29.19 27.76 1811 1863 0.9720 0.9907
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 29.19 27.76 27 1863 0.0145 -0.0046
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 29.19 27.76 1935 1863 1.0386 1.0125
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 30.90 27.76 1243 2032 0.6116 0.8474
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 30.90 27.76 1971 2032 0.9698 0.9901
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 30.90 27.76 34 2032 0.0167 0.0333
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 30.90 27.76 2207 2032 1.0859 1.0268
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 32.60 27.76 1305 2235 0.5837 0.8370
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 32.60 27.76 2116 2235 0.9464 0.9827
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 32.60 27.76 59 2235 0.0264 0.1265
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 32.60 27.76 2396 2235 1.0716 1.0220
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 34.30 27.76 1383 2449 0.5645 0.8307
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 34.30 27.76 2259 2449 0.9221 0.9751
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 34.30 27.76 76 2449 0.0310 0.1686
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 34.30 27.76 2626 2449 1.0719 1.0216
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 36.01 27.76 1439 2662 0.5404 0.8215
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 36.01 27.76 2445 2662 0.9182 0.9742
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 36.01 27.76 93 2662 0.0349 0.2016
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 36.01 27.76 2874 2662 1.0793 1.0233
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 37.71 27.76 1560 2877 0.5421 0.8252
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 37.71 27.76 2618 2877 0.9098 0.9720
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 37.71 27.76 142 2877 0.0493 0.2761
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 37.71 27.76 3106 2877 1.0794 1.0229
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
 39.41 27.76 1835 3105 0.5909 0.8512
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
 39.41 27.76 2828 3105 0.9106 0.9727
MN20160318_Q01
F04